Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health
1 other identifier
interventional
198
1 country
1
Brief Summary
This was a randomized, double-blind, single-center, placebo-controlled, three-arm study. The objectives of this study were to evaluate the effect of the Bright Changyou Probiotic Flavored Yogurt on: Improving gastrointestinal health; Relieving symptoms of functional constipation or functional diarrhea; Improving gut immunity; Adjusting microbiological flora in gastrointestinal tract.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2019
CompletedFirst Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedMay 5, 2020
April 1, 2020
28 days
April 30, 2020
May 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Gastrointestinal health score
Change of the total gastrointestinal health score at day 28 from baseline. The total score is the sum of the 4 aspects of gastrointestinal health (each with score range from 0 to 3): Weekly stool frequency (\>=6; 4-6; 1-3; 0); Ratio of the number of unopened defecation to the total number of defecation (1; 1/4; 1/3; \>=1/2); Duration of defecation (\<5 minutes; 5-15 minutes; 16-30 minutes; \>=30 minutes); Defecation condition (normal perception; straining/uncomfortableness at stool; obvious straining/uncomfortableness or difficulty at defecation with little feces amount; frequent abdominal or anus pain that affect defecation).
Day 0, 28
Secondary Outcomes (7)
Defecation satisfaction score
Day 0, 3, 7, 14, 21, 28
Bristol score of stool characteristics
Day 0, 3, 7, 14, 21, 28
Bristol score of stool color
Day 0, 3, 7, 14, 21, 28
Symptom score of digestive system
Day 0, 3, 7, 14, 21, 28
Fecal bacterium
Day 0, 14
- +2 more secondary outcomes
Study Arms (3)
Bright Changyou probiotic flavored yogurt
EXPERIMENTALBright Changyou probiotic flavored yogurt contains 5.0×10\^8cfu/g of probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum ST-Ⅲ (7mg/kg), and 1.5% of inulin
Bright Changyou lactobacillus flavored yogurt
ACTIVE COMPARATORBright Changyou flavored yogurt contains probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, and Lactobacillus plantarum ST-Ⅲ (7mg/kg)
Bright flavored yogurt
ACTIVE COMPARATORBright flavored yogurt contains Lactobacillus bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei LC2W (0.1 mg/kg)
Interventions
Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.
Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.
Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.
Eligibility Criteria
You may qualify if:
- Men or women aged 25-45 years old;
- Functional constipation or diarrhea diagnosed by Rome III criteria;
- Agree not to take any dietary supplements or dairy products other than the study products during the study period;
- Agree not to take any supplements or dairy products containing prebiotics/probiotics other than the study products during the study period;
- Agree not to participant in other interventional studies during the study period;
- Fully understand the property, purpose, benefits and potential risk and side effect from the study;
- Agree to follow all study requirements and procedures;
- Signed informed consent.
You may not qualify if:
- Currently receiving treatment for gastrointestinal symptoms;
- Lactose intolerance;
- Having diseases or conditions that may affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, or Anorexia nervosa;
- Currently under diet control or in use of medicine or supplements for weight control or that might affect appetite;
- Have had laxatives or other substance that will enhance digestion within two weeks before the study begins;
- Have had dairy products or other food containing probiotics within 10 days before the study begins;
- Currently having diarrhea;
- Currently pregnant or breast-feeding, or plan to be pregnant during the study period;
- Not be able to follow study procedures according to investigators evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Jiaoton University Affiliated Xinhua Hospital
Shanghai, 200092, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2020
First Posted
May 5, 2020
Study Start
February 25, 2019
Primary Completion
March 25, 2019
Study Completion
April 15, 2019
Last Updated
May 5, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share